| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 07/29/2004 | WO2004026816B1 Aromatic liver x-receptor modulators |
| 07/29/2004 | WO2003104181A3 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
| 07/29/2004 | WO2003074990A3 Artificial receptors, building blocks, and methods |
| 07/29/2004 | US20040147748 Increasing insulin secretion; type II diabetes; such as 2-(3-Chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-(5-methylsulfanyl-pyrazin-2-yl)-propionamide |
| 07/29/2004 | US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147598 Cardiovascular disorders; angina pectoris |
| 07/29/2004 | US20040147580 Therapy for bacteria infections |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147559 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/29/2004 | US20040147535 Endothelial growth factor; angiogenesis inhibitor; antitumor agents; skin disorders; endometriosis; Crohn's disease ; leukemia; antiarthritic agents |
| 07/29/2004 | US20040147529 Preferentially substituted calcium channel blockers |
| 07/29/2004 | US20040147516 Blocking interleukins; antiinflammatory agents; autoimmune diseases ; antiarthritic agents; osteoporosis |
| 07/29/2004 | US20040147515 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147503 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; antitumor agents; glomerulonephritis |
| 07/29/2004 | US20040147494 Use |
| 07/29/2004 | US20040147454 Aspartyl protease inhibitors |
| 07/29/2004 | US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation |
| 07/29/2004 | US20040143911 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 07/29/2004 | DE10302500A1 New carboxamide derivatives useful as factor Xa or VIIa inhibitors e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation, stroke and angina |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | CA2512184A1 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 07/28/2004 | EP1441013A1 Watercolor ink |
| 07/28/2004 | EP1440967A1 Process for the preparation of nicotinic acid |
| 07/28/2004 | EP1440061A1 Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| 07/28/2004 | EP1439885A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 07/28/2004 | EP1140862A4 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/28/2004 | EP1073430B1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
| 07/28/2004 | EP1058698B1 Preparation for prevention and healing of inflammation affections |
| 07/28/2004 | EP1051383B1 Hydroxylation activated prodrugs |
| 07/28/2004 | EP0823897B1 Nicotinic acid esters and pharmaceutical compositions containing them |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | CN1516713A Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1516691A Phenylpyridine carbonyl piperazine derivative |
| 07/28/2004 | CN1516690A Heterocyclic derivatives and medicines |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1515554A Intermediate compound for producing 2-amino-6-(2-substituted-4-phenoxy) substituted pyridine compound |
| 07/28/2004 | CN1159311C Dihydropyrimidines |
| 07/28/2004 | CN1159297C N-([1,2,4]triazoleo azine group) benzene sulfonamide and pyridine sulfamide compound and their use as herbicide |
| 07/28/2004 | CN1159293C 5-aroylnaphthalene derivatives |
| 07/28/2004 | CN1159290C Method for preparing biocide alkyl-substituted (hetero)-aryl-ketoxime-o-ether and its intermediate ketone or oxime compounds |
| 07/28/2004 | CN1159278C Fungicidal methods, compounds and compositions contg. benzophenones |
| 07/28/2004 | CN1159104C Super-nucleophilic 4-substituted-pyridine catalyst and preparation method thereof |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | CA2118512C Agents for treating substance abuse disorders |
| 07/22/2004 | WO2004060882A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 07/22/2004 | WO2004060859A2 Novel amides that activate soluble guanylate cyclase |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004037773A8 Phenethanolamine derivative for the treatment of respiratory diseases |
| 07/22/2004 | WO2003076426A3 Pyridinyloxy derivatives as 5-ht receptor ligands |
| 07/22/2004 | US20040143107 2,2-bis(p-(o-(6-hydroxy-4-methyl-3-CN, CHON2 or CH2SO3H-pyridon-5-ylazo)phenylsulfonyloxy)phenyl)propane derivattives; improved heat resistance, migration characteristics and tinctorial strength |
| 07/22/2004 | US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst |
| 07/22/2004 | US20040143006 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142984 Applying to plants |
| 07/22/2004 | US20040142983 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/22/2004 | US20040142977 4-Substituted-picolinic acid amide derivatives useful as fungicides |
| 07/22/2004 | US20040142972 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142924 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 07/22/2004 | US20040142921 treatment and/or prevention of type 2 diabetes and associated metabolic syndrome |
| 07/22/2004 | US20040142919 Benzazepinone alpha vintegrin receptor antagonists |
| 07/22/2004 | US20040142878 N-cycloalkylglycines as HIV protease inhibitors |
| 07/22/2004 | US20040142851 by inducing the apoptosis according to a inhibition mechanism of the enzyme activities of proteasome |
| 07/22/2004 | US20040142843 Use of metal complex compounds as oxidation catalysts |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/21/2004 | EP1439187A1 O2-Arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1439165A1 Abscisic acid biosynthesis inhibitor |
| 07/21/2004 | EP1439157A2 Method for producing Suzuki coupling compound catalysed by a nickel compound |
| 07/21/2004 | EP1438302A1 New sulfonamide derivatives as d3-receptor agonists |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1438038A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1078920B1 Process for producing pyridine derivative through reaction of azametal lacyclo pentadiene with alkyne |
| 07/21/2004 | EP1047692B1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 07/21/2004 | EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| 07/21/2004 | CN1514824A Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 07/21/2004 | CN1513840A Production method of 3,5,6-trichloro pyridine-2-phenolate |
| 07/21/2004 | CN1513839A Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation |
| 07/21/2004 | CN1158269C 4-aminothiazole 2 group compound as inhibitors of cyclin-dependent kinases |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 07/21/2004 | CN1158263C Method of treating textile |